ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Neumora Therapeutics Inc

Neumora Therapeutics Inc (NMRA)

13.08
0.28
(2.19%)
Closed September 26 3:00PM
13.08
0.00
( 0.00% )
Pre Market: 6:36AM

Income Statement

Balance Sheet

Cash Flow

Quarter End Sep 2023Dec 2023Mar 2024Jun 2024
USD (US$)USD (US$)USD (US$)
Total Revenue 0000
Operating Income -56.86M-114M-60.07M-63.82M
Pre Tax Income -53.03M-108.46M-53.72M-58.58M
Net Income -53.03M-108.73M-53.72M-58.7M
Preferred Dividends 0000
Basic Earnings Per Share (EPS) 0000
EBIT -56.87M-114.11M-60.09M-63.85M
EBITDA -56.69M-113.84M-59.92M-63.66M
Year End December 30 2023 202120222023
USD (US$)USD (US$)USD (US$)
Total Revenue 000
Operating Income -237.32M-135.87M-252.1M
Pre Tax Income -237.31M-130.9M-235.66M
Net Income -237.31M-130.9M-235.93M
Preferred Dividends 000
Basic Earnings Per Share (EPS) -0.239-0.256-0.575
EBIT -237.31M-135.47M-252.27M
EBITDA -236.79M-135.28M-251.43M